Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Transformed Mycosis Fungoides: Clinical and Pathologic Characteristics in a Single Center Retrospective Analysis

Pamela Allen, Katherine Case, Tony Zhuang, Mark Justin Jedrzejczak, Erica Shantha Tarabadkar, Mary Jo Lechowicz, Samuel S Bidot, Saja Asakrah

Blood (2021) 138 (Supplement 1): 2446.

https://doi.org/10.1182/blood-2021-153985

Published: 2021

Journal Articles

No Difference in Survival Among Black Patients with Mycosis Fungoides and Sézary Syndrome: A Multicenter Retrospective Analysis

Pamela Allen, Subir Goyal, Irl Brian Greenwell, Jane Scribner, Sunil Rangarajan, Amitkumar Mehta, Colin Burke O'Leary, Tim Niyogusaba, Auris Huen, Jeffrey M. Switchenko, Erica Shantha Tarabadkar, Amy Ayers, Shalini Krishnasamy, Pierluigi Porcu, Tarsheen Sethi, Swaminathan P Iyer, Mary Jo Lechowicz

Blood (2021) 138 (Supplement 1): 2441.

https://doi.org/10.1182/blood-2021-151911

Published: 2021

Journal Articles

Atezolizumab Combined with Immunogenic Salvage Chemoimmunotherapy (R-GemOx+Atezo) in Patients with Transformed Diffuse Large B-Cell Lymphoma

Alex F. Herrera, Tamer Othman, Paul Frankel, Pamela Allen, Leslie L. Popplewell, Geoffrey Shouse, Tanya Siddiqi, Alexey V. Danilov, Nora Ruel, Shari Daniels, Lacolle Peters, Stella Khoo, Steven T. Rosen, Elad Sharon, Joseph M Tuscano

Blood (2021) 138 (Supplement 1): 1407.

https://doi.org/10.1182/blood-2021-151188

Published: 2021

Journal Articles

A Multi-Institutional Retrospective Analysis of T-Cell Lymphomas with Central Nervous System Relapse

Blood (2021) 138 (Supplement 1): 1382.

https://doi.org/10.1182/blood-2021-148868

Published: 2021

Journal Articles

Risk Factors for Progression from Early to Advanced Stage Mycosis Fungoides: A Single Center Retrospective Analysis at the Winship Cancer Institute of Emory University

Pamela Allen, Ashley Alesia McCook, Jeffrey M. Switchenko, Shaunak Varma, Mary Jo Lechowicz, Erica Shantha Tarabadkar

Blood (2021) 138 (Supplement 1): 1378.

https://doi.org/10.1182/blood-2021-146590

Published: 2021

Journal Articles

Frontline Treatment with Single Agent Pembrolizumab (PEM) Followed By AVD Chemotherapy for Classic Hodgkin Lymphoma: Updated Results and Correlative Analysis

Pamela Allen, Qing C Chen, Xinyan Lu, Kaitlyn O'Shea, Joan Chmiel, Madina Sukhanova, Liron Barnea Slonim, Hatice Savas, Eric Mou, Barbara Pro, Andrew M. Evens, Brett Alan Palmer, Ranjana Advani, Leo I. Gordon, Jane N. Winter

Blood (2021) 138 (Supplement 1): 231.

https://doi.org/10.1182/blood-2021-147042

Published: 2021

Journal Articles

Pembrolizumab (PEM) Added to ICE Chemotherapy Results in High Complete Metabolic Response Rates in Relapsed/Refractory Classic Hodgkin Lymphoma (cHL): A Multi-Institutional Phase II Trial

Locke J. Bryan, Carla Casulo, Pamela Allen, Scott E. Smith, Hatice Savas, Reem Karmali, Barbara Pro, Kaitlyn O'Shea, Joan Chmiel, Brett Alan Palmer, Jayesh Mehta, Leo I. Gordon, Jane N. Winter

Blood (2021) 138 (Supplement 1): 229.

https://doi.org/10.1182/blood-2021-145111

Published: 2021

Journal Articles

Hepatosplenic T-cell lymphoma: a rare but challenging entity

Barbara Pro, Pamela Allen, Amir Behdad

Blood (2020) 136 (18): 2018–2026.

https://doi.org/10.1182/blood.2019004118

Published: 2020

Journal Articles

North American Practice Patterns for PET-2 Positive Hodgkin Lymphoma

Blood (2019) 134 (Supplement_1): 1553.

https://doi.org/10.1182/blood-2019-131276

Published: 2019

Journal Articles

Brief Pembrolizumab(PEM) Monotherapy Results in Complete and Near Complete Responses in the Majority of Untreated Patients with Classical Hodgkin Lymphoma (cHL): A Multicenter Phase 2 PET-Adapted Study of Sequential PEM and AVD

Pamela Allen, MD MSc, Hatice Savas, MD, Andrew M. Evens, DO,MSc, Barbara Pro, MD, Reem Karmali, MD, Brett Alan Palmer, BS, Eric Mou, MD, Jeffrey Bearden, BA, Denise M Scholtens, PhD, Gary Dillehay, MD, Leo I. Gordon, MD, Jane N. Winter, MD

Blood (2019) 134 (Supplement_1): 235.

https://doi.org/10.1182/blood-2019-123906

Published: 2019

Journal Articles

Characteristics, Treatment Patterns, and Outcomes in Primary Cutaneous Gamma Delta T Cell Lymphoma (PCGDTCL): A Real World Multi-Institutional Analysis of a Rare Malignancy

Blood (2019) 134 (Supplement_1): 4028.

https://doi.org/10.1182/blood-2019-130223

Published: 2019

Journal Articles

Safety and Toxicity Profile of Pembrolizumab (PEM) in Combination with ICE Chemotherapy Followed By Autologous Stem Cell Transplantation for Relapsed/Refractory Classical Hodgkin Lymphoma: No Impairment in Stem Cell Mobilization or Engraftment

Locke J. Bryan, MD, Scott E. Smith, MD PhD, Pamela Allen, MDMSc, Carla Casulo, Brett Alan Palmer, BS, Reem Karmali, MD, Barbara Pro, MD, Denise M Scholtens, PhD, Hatice Savas, MD, Jayesh Mehta, MD, Leo I. Gordon, MD, Jane N. Winter, MD

Blood (2019) 134 (Supplement_1): 4029.

https://doi.org/10.1182/blood-2019-123879

Published: 2019

Journal Articles

Mortality and Risk Factors for Bacteremia in Patients with Cutaneous T-Cell Lymphoma (CTCL) at Emory University

Pamela Allen, MDMSc, Esther Kim, Amy Ayers, MPH, Mary Jo Lechowicz, MD

Blood (2019) 134 (Supplement_1): 4043.

https://doi.org/10.1182/blood-2019-131626

Published: 2019

Journal Articles

Influenza Vaccination Rates during the First Year after Diagnosis of Diffuse Large B Cell Lymphoma

Andres Chang, MD PhD, Jackelyn B. Payne, MPH, BS, BA, Pamela Allen, MD MSc, Jean L. Koff, MD, Rafi Ahmed, PhD, Christopher R Flowers, MD MS, Robert A Bednarczyk, PhD

Blood (2018) 132 (Supplement 1): 4820.

https://doi.org/10.1182/blood-2018-99-117168

Published: 2018

Journal Articles

The Impact of a Physical Activity Intervention Can be Accurately Assessed By Smart Watches in Patients Completing Autologous Stem Cell Transplantation for Lymphoma or Multiple Myeloma: Results of a Feasibility Study

Blood (2018) 132 (Supplement 1): 5911.

https://doi.org/10.1182/blood-2018-99-119757

Published: 2018

Journal Articles

Evaluation of All Cause of Death after High Dose Chemotherapy and Autologous Stem Cell Transplant in Hodgkin Lymphoma and Non-Hodgkin Lymphoma

Blood (2018) 132 (Supplement 1): 2157.

https://doi.org/10.1182/blood-2018-99-118896

Published: 2018

Journal Articles

Evaluation of Maintenance Therapy in Cutaneous T-Cell Lymphoma Patients Receiving Total Skin Electron Beam Radiation Therapy

Matthew Kudelka, Mary Jo Lechowicz, MD, Mohammad K Khan, MD, PhD, Natia Esiashvili, MD, Christopher R Flowers, MDMS, Pamela Allen, MDMSc

Blood (2018) 132 (Supplement 1): 1639.

https://doi.org/10.1182/blood-2018-99-111078

Published: 2018

Journal Articles

A Phase II StudyÂ of Sequential Pembrolizumab (PEM)Â FollowedÂ By AVD for Frontline TreatmentÂ of Classical Hodgkin Lymphoma (CHL): Quantifying Response FollowingÂ PEM MonotherapyÂ with FDG-PET-Derived Metabolic Tumor Volume and Total Lesion Glycolysis

Hatice Savas, MD, Pamela Allen, MDMSc, Andrew M. Evens, DO, MSc, Barbara Pro, MD, Gary Dillehay, MD, Alfred Rademaker, PhD, Brett Alan Palmer, BS, Ranjana Advani, MD, Leo I. Gordon, MD, Jane N. Winter, MD

Blood (2018) 132 (Supplement 1): 1651.

https://doi.org/10.1182/blood-2018-99-113836

Published: 2018

Journal Articles

Radiation Pneumonitis Risk after Bleomycin Toxicity in Hodgkin Lymphoma Patients

Zeinab A Abou Yehia, MD, George Mikhaeel, MD, Grace Smith, MD, Chelsea C Pinnix, MDPhD, Sarah A Milgrom, MD, Michelle A. Fanale, MD, Jay Reddy, MD, Eleanor Osborne, MD, Mani Akhtari, MD, Jillian Gunther, MD, Pamela Allen, PhD, Bouthaina S. Dabaja, MD

Blood (2015) 126 (23): 1511.

https://doi.org/10.1182/blood.V126.23.1511.1511

Published: 2015

Journal Articles

Either Combined-Modality Or Radiotherapy Alone Provide Favorable Outcome In Stage I-II Mantle Cell Lymphoma: A Report Of 82 Patients From The International Lymphoma Radiation Oncology Group (ILROG)

Bouthaina S. Dabaja, MD, Richard Tsang, MD, Shunan Qi, Pamela Allen, PhD, David C. Hodgson, MD, Umberto Ricardi, MD, Richard T. Hoppe, MD, Andrea Ng, Lena Specht, Ye-xiong Li, MD, Stephanie Terezakis, MD, Louis Constine, MD, Joachim Yahalom, MD

Blood (2013) 122 (21): 4292.

https://doi.org/10.1182/blood.V122.21.4292.4292

Published: 2013

NARROW

Transformed Mycosis Fungoides: Clinical and Pathologic Characteristics in a Single Center Retrospective Analysis

No Difference in Survival Among Black Patients with Mycosis Fungoides and Sézary Syndrome: A Multicenter Retrospective Analysis

Atezolizumab Combined with Immunogenic Salvage Chemoimmunotherapy (R-GemOx+Atezo) in Patients with Transformed Diffuse Large B-Cell Lymphoma

A Multi-Institutional Retrospective Analysis of T-Cell Lymphomas with Central Nervous System Relapse

Risk Factors for Progression from Early to Advanced Stage Mycosis Fungoides: A Single Center Retrospective Analysis at the Winship Cancer Institute of Emory University

Frontline Treatment with Single Agent Pembrolizumab (PEM) Followed By AVD Chemotherapy for Classic Hodgkin Lymphoma: Updated Results and Correlative Analysis

Pembrolizumab (PEM) Added to ICE Chemotherapy Results in High Complete Metabolic Response Rates in Relapsed/Refractory Classic Hodgkin Lymphoma (cHL): A Multi-Institutional Phase II Trial

Hepatosplenic T-cell lymphoma: a rare but challenging entity

North American Practice Patterns for PET-2 Positive Hodgkin Lymphoma

Brief Pembrolizumab(PEM) Monotherapy Results in Complete and Near Complete Responses in the Majority of Untreated Patients with Classical Hodgkin Lymphoma (cHL): A Multicenter Phase 2 PET-Adapted Study of Sequential PEM and AVD

Characteristics, Treatment Patterns, and Outcomes in Primary Cutaneous Gamma Delta T Cell Lymphoma (PCGDTCL): A Real World Multi-Institutional Analysis of a Rare Malignancy

Safety and Toxicity Profile of Pembrolizumab (PEM) in Combination with ICE Chemotherapy Followed By Autologous Stem Cell Transplantation for Relapsed/Refractory Classical Hodgkin Lymphoma: No Impairment in Stem Cell Mobilization or Engraftment

Mortality and Risk Factors for Bacteremia in Patients with Cutaneous T-Cell Lymphoma (CTCL) at Emory University

Influenza Vaccination Rates during the First Year after Diagnosis of Diffuse Large B Cell Lymphoma

The Impact of a Physical Activity Intervention Can be Accurately Assessed By Smart Watches in Patients Completing Autologous Stem Cell Transplantation for Lymphoma or Multiple Myeloma: Results of a Feasibility Study

Evaluation of All Cause of Death after High Dose Chemotherapy and Autologous Stem Cell Transplant in Hodgkin Lymphoma and Non-Hodgkin Lymphoma

Evaluation of Maintenance Therapy in Cutaneous T-Cell Lymphoma Patients Receiving Total Skin Electron Beam Radiation Therapy

A Phase II StudyÂ of Sequential Pembrolizumab (PEM)Â FollowedÂ By AVD for Frontline TreatmentÂ of Classical Hodgkin Lymphoma (CHL): Quantifying Response FollowingÂ PEM MonotherapyÂ with FDG-PET-Derived Metabolic Tumor Volume and Total Lesion Glycolysis

Radiation Pneumonitis Risk after Bleomycin Toxicity in Hodgkin Lymphoma Patients

Either Combined-Modality Or Radiotherapy Alone Provide Favorable Outcome In Stage I-II Mantle Cell Lymphoma: A Report Of 82 Patients From The International Lymphoma Radiation Oncology Group (ILROG)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only